marketing-medtech

**Founder:** Karina Léa Schönborn — Présidente (founder / sole shareholder)
**Background:** unknown | verified: True — Karina Léa Schönborn (born 1993) is a trained osteopath (Ostéopathe D.O., diploma from IFOGA – Institut de Formation en Ostéopathie du Grand-Avignon) practicing in Montpellier. From that healthcare-practitioner background she founded and is sole shareholder/Présidente of MILO HEALTH SASU (SIREN 985 118 041, created March 2024), a medical-software company (NAF 6201Z – computer programming) building software for hospitals, physicians, MedTech/industry and patients (clinical research / EDC platform). The company was originally registered in Montpellier and later moved its HQ to Paris.
**Stage / fundraise:** Very early. SASU created 2024-02-12 (~28 months old as of June 2026), €1,000 share capital, 0 declared employees. / No fundraising confirmed; likely pre-seed / bootstrapped.
**Regulatory trigger:** Declared corporate purpose is "logiciel médical pour les hôpitaux, médecins, industriels et patients" (medical software for hospitals, physicians, industry and patients), NAF 62.01Z. Software intended for clinical/patient use is likely SaMD with MDR Class IIa exposure and an IEC 62304 lifecycle obligation — but no product, CE marking status, or clinical claim is published yet, so the specific trigger is unconfirmed.
**Email:** (confidence none) — No published email for this entity or for Karina Schönborn. No confirmed company domain (the milo-healthcare.com domain and its Clientcare@milo-healthcare.com address belong to ECLEVAR's Milo, a different company — NOT this candidate, so it cannot be used). No email pattern can be inferred without a confirmed domain. Leaving blank per hard rules.
**LinkedIn:** https://www.linkedin.com/in/karina-sch%C3%B6nborn-1500a397/ (founder); company page https://www.linkedin.com/company/milohealth **Website:**
**Score:** 7 -> Tier B
**Hook:** A solo-founder SASU building medical software for hospitals/physicians, with zero registered employees and no CTO, is staring at the exact gap OmDev fills: a senior dev team plus a dedicated CTO at a fixed monthly price ~3x cheaper than hiring in-house — and, because the purpose is medical software, OmDev's pipeline produces the MDR/IEC 62304 evidence (SOUP register signed each build, requirements-to-code-to-test traceability) so Karina builds the product AND the regulatory file at once, while keeping ownership of the code. Lead with the build-team-plus-compliance-engine angle, not a funding assumption.

---

## Founder & background
Karina Léa Schönborn (born Nov 1993) is Présidente and sole shareholder of MILO HEALTH SASU, in post since 2024-06-29 ([Pappers](https://www.pappers.fr/entreprise/milo-health-985118041)). Her background is NOT verified: the LinkedIn profile is access-blocked, and a single low-confidence snippet shows the title "Director of Strategic Partnerships" — suggestive of a commercial/non-technical profile but unconfirmed ([LinkedIn](https://www.linkedin.com/in/karina-sch%C3%B6nborn-1500a397/)). No source supports a finance, insurance, pharma, clinical or tech claim, so none is asserted.

## Funding & momentum
SASU created 2024-02-12, €1,000 share capital, 0 declared employees, HQ 58 rue de Monceau 75008 Paris plus a secondary establishment at 229 rue Saint-Honoré 75001 ([annuaire-entreprises](https://annuaire-entreprises.data.gouv.fr/etablissement/98511804100021)). No fundraising, BPI grant, or press coverage was found — momentum reads as pre-seed/bootstrapped. At ~28 months old it sits just past the 24-month early window.

## Product & regulatory
Declared purpose: "logiciel médical pour les hôpitaux, médecins, industriels et patients," NAF 62.01Z ([Pappers](https://www.pappers.fr/entreprise/milo-health-985118041)). Medical software for clinical/patient use typically means SaMD with MDR + IEC 62304 obligations, but no product, website, or CE status is public for this entity. NOTE: the milo-healthcare.com EDC platform is a DIFFERENT company (ECLEVAR MedTech, CEO Chems Hachani) and must not be attributed here ([Ballas Invest](https://www.ballasinvest.com/post/milo-ai-clinical-trial-platform-by-eclevar)).

## Pain & buying signals
Solo founder, 0 employees, no registered CTO or dev team — the textbook build-vs-buy gap for a medical-software project carrying an MDR/IEC 62304 compliance load no single founder can staff for ([Pappers](https://www.pappers.fr/entreprise/milo-health-985118041)). Two establishments hint at real activity, but no traction signals (product, funding, hires) are public.

**Why OmDev fits:** OmDev gives Karina a senior dev team + a dedicated CTO at a fixed monthly price ~3x cheaper than building in-house, while keeping her the owner of the code — and because the purpose is medical software, OmDev's pipeline outputs MDR/IEC 62304 evidence (signed SOUP register per build + requirements-to-code-to-test traceability) so she builds the product and the regulatory file in one motion. Reference points: CadSmile, SpeechLink. (Diligence flag: confirm she is actively building a product and not merely a partnerships entity before outreach; lead with team-plus-compliance, not a funding assumption.)

---
**Sources:** https://www.pappers.fr/entreprise/milo-health-985118041 · https://annuaire-entreprises.data.gouv.fr/etablissement/98511804100021 · https://recherche-entreprises.api.gouv.fr/search?q=985118041 · https://data.inpi.fr/entreprises/985118041 · https://www.linkedin.com/in/karina-sch%C3%B6nborn-1500a397/ · https://www.linkedin.com/company/milohealth · https://milo-healthcare.com/en/contact/ · https://www.ballasinvest.com/post/milo-ai-clinical-trial-platform-by-eclevar